publicaciones seleccionadas documento Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial 2022-10 Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial 2022-10
Lady T. Giratá Viviescas
|
Persona
